Journal article
Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry.
Abstract
OBJECTIVE: Tofacitinib (TOF) is an oral, small-molecule drug used for rheumatoid arthritis (RA) treatment and is one of several alternative treatments to tumor necrosis factor inhibitors (TNFi). We evaluated physician- and patient-reported effectiveness of TNFi compared to TOF, using real-world data from the Ontario Best Practices Research Initiative (OBRI).
METHODS: Patients enrolled in the OBRI initiating TOF or TNFi between 2014 and 2019 …
Authors
Movahedi M; Cesta A; Li X; Keystone EC; Bombardier C
Journal
The Journal of Rheumatology, Vol. 49, No. 5, pp. 447–453
Publisher
The Journal of Rheumatology
Publication Date
May 2022
DOI
10.3899/jrheum.211066
ISSN
0315-162X